Erratum: Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease (Neuroscience Letters (2004) 355 (193-196) DOI:10.1016/j.neulet.2003.11.006);Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease

Neuroscience Letters

Volumn 355, Issue 3, 2004, Pages 193-196

  Wang, Jian ^a,d   Zhao, Chunying ^a   Chen, Biao ^b   Liu, Zhuo Lin ^c  

^a FUDAN UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

Dopamine; Gene polymorphism; Hallucination; Parkinson's disease; Receptor; Transporter

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; TRANSFER RNA; CARRIER PROTEIN; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; MEMBRANE PROTEIN; NERVE PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR GENE; VARIABLE NUMBER OF TANDEM REPEAT; VISUAL HALLUCINATION; ALLELE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; FOLLOW UP; GENE FREQUENCY; GENETICS; HALLUCINATION; MIDDLE AGED; NONPARAMETRIC TEST;

AGED; ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HALLUCINATIONS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE; STATISTICS, NONPARAMETRIC;

EID: 1542287193     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.11.078     Document Type: Erratum

References (19)

1. Fenelon G., Mahieux F., Huon R., Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain. 123:2000;733-745.
2. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenom. J. 1:2001;152-156.
3. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson's disease. Arch. Neurol. 56:1999;33-39.
4. Goetz C.G., Burke P.F., Leurgans S., Berry-Kravis E., Blasucci L.M., Raman R., Zhou L. Genetic variation analysis in Parkinson disease patients with and without hallucinations: case-control study. Arch. Neurol. 58:2001;209-213.
5. Grandy D.K., Zhang Y., Civelli O. PCR detection of the TaqI A RFLP at the DRD2 locus. Hum. Mol. Genet. 2:1993;2197.
6. Griffon N., Crocq M.A., Pilon C., Martres M.P., Mayerova A., Uyanik G., Burgert E., Duval F., Macher J.P., Javoy-Agid F., Tamminga C.A., Schwartz J.C., Sokoloff P. Dopamine D3 receptor gene: organization, transcript variants, and polymorphism associated with schizophrenia. Am. J. Med. Genet. 67:1996;63-70.
7. Jonsson E.G., Nothen M.M., Grunhage F., Farde L., Nakashima Y., Propping P., Sedvall G.C. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol. Psychiatry. 4:1999;290-296.
8. Kaiser R., Hofer A., Grapengiesser A., Gasser T., Kupsch A., Roots I., Brockmoller J. L-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. Neurology. 60:2003;1750-1755.
9. Kim J.W., Kim D.H., Kim S.H., Cha J.K. Association of the dopamine transporter gene with Parkinson's disease in Korean patients. J. Korean Med. Sci. 15:2000;449-451.
10. Le Couteur D.G., Leighton P.W., McCann S.J., Pond S. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease. Mov. Disord. 12:1997;760-763.
11. Lundstrom K., Turpin M.P. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochem. Biophys. Res. Commun. 225:1999;1068-1072.
12. Makoff A.J., Graham J.M., Arranz M.J., Forsyth J., Li T., Aitchison K.J., Shaikh S., Grunewald R.A. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics. 10:2000;43-48.
13. Miller G.M., Madras B.K. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol. Psychiatry. 7:2002;44-55.
14. Oliveri R.L., Annesi G., Zappia M., Civitelli D., Montesanti R., Branca D., Nicoletti G., Spadafora P., Pasqua A.A., Cittadella R., Andreoli V., Gambardella A., Aguglia U., Quattrone A. Dopamine D2 receptor gene polymorphism and the risk of levodopa-induced dyskinesias in PD. Neurology. 53:1999;1425-1430.
15. Ritchie T., Noble E.P. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem. Res. 28:2003;73-82.
16. Wang J., Liu Z.L., Chen B. Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD. Neurology. 56:2001;1757-1759.
17. Wang J., Liu Z., Chen B. Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease. Zhonghua Yi Xue Za Zhi. 80:2000;346-348.
18. Wang J., Liu Z.L., Chen B. Dopamine D5 receptor gene polymorphism and the risk of levodopa-induced motor fluctuations in patients with Parkinson's disease. Neurosci. Lett. 308:2001;21-24.
19. Wang J., Si Y.M., Liu Z.L., Yu L. Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease. Pharmacogenetics. 13:2003;365-369.